Cargando…
Berberine reduces temozolomide resistance by inducing autophagy via the ERK1/2 signaling pathway in glioblastoma
BACKGROUND: The ability to treat glioblastoma (GBM) using the chemotherapeutic agent temozolomide (TMZ) has been hampered by the development of therapeutic resistance. In this study, we assessed the ability of the isoquinoline alkaloid berberine to alter GBM TMZ resistance using two different TMZ-re...
Autores principales: | Qu, Huiling, Song, Xiaofu, Song, Zhuyin, Jiang, Xin, Gao, Xin, Bai, Lijuan, Wu, Jiao, Na, Li, Yao, Zhicheng |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7727240/ https://www.ncbi.nlm.nih.gov/pubmed/33298057 http://dx.doi.org/10.1186/s12935-020-01693-y |
Ejemplares similares
-
Knockdown lncRNA CRNDE enhances temozolomide chemosensitivity by regulating autophagy in glioblastoma
por: Zhao, Zijin, et al.
Publicado: (2021) -
Temozolomide promotes genomic and phenotypic changes in glioblastoma cells
por: Stepanenko, Aleksei A., et al.
Publicado: (2016) -
Levetiracetam enhances the temozolomide effect on glioblastoma stem cell proliferation and apoptosis
por: Scicchitano, Bianca Maria, et al.
Publicado: (2018) -
Marsdenia tenacissima extract induces apoptosis and suppresses autophagy through ERK activation in lung cancer cells
por: Jiao, Yan-Na, et al.
Publicado: (2018) -
Hedgehog/Gli1 signaling pathway regulates MGMT expression and chemoresistance to temozolomide in human glioblastoma
por: Wang, Ke, et al.
Publicado: (2017)